other material
confidence high
sentiment neutral
materiality 0.30
GeneDx regains Nasdaq minimum bid price compliance after reverse stock split
GeneDx Holdings Corp.
- Nasdaq notified GeneDx on May 18, 2023 that it met $1.00 minimum bid for 10 consecutive days.
- Company had previously received deficiency notice on Dec 28, 2022 for bid price below $1.00.
- Compliance achieved after 1-for-33 reverse stock split effective May 4, 2023.
- Nasdaq confirmed the matter is closed and listing continues on the Global Select Market.